Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07087743 · ClinicalTrials.gov registry record · NA

Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab

A NA study of Stroke and Virtual Reality, sponsored by The University of Texas Medical Branch, Galveston.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07087743: Recruiting NA study of Stroke and Virtual Reality, sponsored by The University of Texas Medical Branch, Galveston.

NCT07087743 is a NA study of Stroke and Virtual Reality that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 30 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07087743, a NA study of Stroke and Virtual Reality, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study evaluates a novel Virtual Reality (VR)-integrated visual feedback system designed to enhance limb propulsion during robot-assisted gait rehabilitation in individuals post-stroke. In collaboration with CUREXO, a rehabilitation robotics company, the system is embedded within the Morning Walk® end-effector robot and provides real-time visual feedback to facilitate symmetrical use of the paretic and non-paretic limbs. The goal is to address gait asymmetry commonly observed in hemiparetic stroke survivors by promoting improved paretic leg propulsion, which is a key contributor to forward movement during walking. A total of 30 participants (15 stroke, 15 healthy controls) aged 20 years or older will undergo single-session gait training using the VR-robot system. Participants will be assessed using spatiotemporal gait parameters, muscle activity, foot pressure, and vertical ground reaction forces. Additional safety measures-including a saddle-type weight support and real-time heart rate monitoring via smartwatch-are implemented to ensure a safe and controlled training environment. This study aims to test the feasibility and effectiveness of this VR-based system in improving gait symmetry and functional walking capacity in people recovering from stroke.

Primary Outcome

Spatiotemporal gait parameters will be collected using the Zeno Walkway GaitMat before and after a single session of VR-based gait training. Gait spatiotemporal parameters will be calculated from the ratio of step lengths (paretic/non-paretic in stroke group; left/right in healthy group). The step length will be compared pre- and post-training.

Interventions

  • BEHAVIORAL VR-Based Gait Training with End-Effector Robot

Study Locations (1)

Texas

  • University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-07-25
Est. Completion 2026-04-30
Phase NA

What NCT07087743 shows while recruiting

NCT07087743 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which VR-Based Gait Training with End-Effector Robot is the first listed.

NCT07087743 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07087743 about?

NCT07087743 is a clinical study titled "Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab". This study evaluates a novel Virtual Reality (VR)-integrated visual feedback system designed to enhance limb propulsion during robot-assisted gait rehabilitation in individuals post-stroke. In collaboration with CUREXO, a rehabilitation robotics company, the system is embedded within the Morning Wal...

What is the current status of trial NCT07087743?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-07-25. Estimated completion is 2026-04-30.

What conditions does trial NCT07087743 study?

This clinical trial studies the following conditions: Stroke, Virtual Reality, Robot Assisted Gait Training.

What interventions are being tested in trial NCT07087743?

The interventions under investigation include: VR-Based Gait Training with End-Effector Robot (BEHAVIORAL).

Who is sponsoring clinical trial NCT07087743?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07087743 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07087743's enrollment target sits among peer trials

30 301st of 454 higher than 137 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07087743, the US trial registry maintained by the National Library of Medicine. NCT07087743 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.